Is elagolix safe and effective in the treatment of endometriosis pain?

Thomas Kern, Jocelyn Gray, Palak Krushiker, Ty Dulworth

In: Evidence-Based Practice · 2022 · vol. 25(12) , pp. 26–27 · doi:10.1097/ebp.0000000000001574 · W4283031284

article OA: closed CC0

View on OpenAlex View at publisher

Abstract

Kern, Thomas MD; Gray, Jocelyn MD; Krushiker, Palak MD; Dulworth, Ty Author Information

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study 2013

References (2)

Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study via openalex
W3048062679 via openalex

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall: last seen: 2026-06-05T02:00:03.366016+00:00

License: CC0 · commercial use OK